Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1354-1361

  Alexander, Jessy J ^a   Aneziokoro, O G B ^a   Chang, Anthony ^c   Hack, Bradley K ^a   Markaryan, Adam ^a   Jacob, Alexander ^a   Luo, Roger ^b   Thirman, Michael ^b   Haas, Mark ^d   Quigg, Richard J ^a,e  

^a UNIVERSITY OF CHICAGO   (United States)

^b SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT FACTOR H;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL CULTURE; CHIMERA; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE MODEL; GLOMERULITIS; GLOMERULUS; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; THROMBOCYTE;

EID: 33646354404     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006020138     Document Type: Article

References (53)

1. Walport MJ: Complement (first of two parts). N Engl J Med 344: 1058-1066, 2001
2. Carroll MC: The complement system in regulation of adaptive immunity. Nat Immunol 5: 981-986, 2004
3. Hebert LA: The clearance of immune complexes from the circulation of man and other primates. Am J Kidney Dis 27: 352-361, 1991
4. Edberg JC, Tosic L, Taylor RP: Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice. Clin Immunol Immunopathol 51: 118-132, 1989
5. Alexander JJ, Hack BK, Cunningham PN, Quigg RJ: A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor. J Biol Chem 276: 32129-32135, 2001
6. Morgan BP, Harris CL: Regulation in the activation pathways. In: Complement Regulatory Proteins, San Diego, Academic Press, 1999, pp 41-136
7. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP: Control of the complement system. Adv Immunol 61: 201-283, 1996
8. Pangburn MK, Pangburn KL, Koistinen V, Meri S, Sharma AK: Molecular mechanisms of target recognition in an innate immune system: Interactions among factor H, C3b, and target in the alternative pathway of human complement. J Immunol 164: 4742-4751, 2000
9. Zipfel PF, Hellwage J, Friese MA, Hegasy G, Jokiranta ST, Meri S: Factor H and disease: A complement regulator affects vital body functions. Mol Immunol 36: 241-248, 1999
10. Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF: Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111: 1181-1190, 2003
11. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, Sangiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J: Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389, 2005
12. Malhotra V, Sim RB: Expression of complement factor H on the cell surface of the human monocytic cell line U937. Eur J Immunol 15: 935-941, 1985
13. Ren G, Doshi M, Hack BK, Alexander JJ, Quigg RJ: Rat glomerular epithelial cells produce and bear factor H on their surface which is upregulated under complement attack. Kidney Int 64: 914-922, 2003
14. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31: 424-428, 2002
15. Stilmant MM, Couser WG, Cotran RS: Experimental glomerulonephritis in the mouse associated with mesangial deposition of autologous ferritin immune complexes. Lab Invest 32: 746-756, 1975
16. Iskandar SS, Jennette JC, Wilkman AS, Becker RL: Interstrain variations in nephritogenicity of heterologous protein in mice. Lab Invest 46: 344-351, 1982
17. Falk RJ, Jennette JC: Immune complex induced glomerular lesions in C5 sufficient and deficient mice. Kidney Int 30: 678-686, 1986
18. Alexander JJ, Pickering MC, Haas M, Osawe I, Quigg RJ: Complement factor H limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. J Am Soc Nephrol 16: 52-57, 2005
19. Quigg RJ, Alexander JJ, Lo CF, Lim A, He C, Holers VM: Characterization of C3-binding proteins on mouse neutrophils and platelets. J Immunol 159: 2438-2444, 1997
20. Drachman JG, Sabath DF, Fox NE, Kaushansky K: Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 89: 483-492, 1997
21. Italiano JE Jr, Lecine P, Shivdasani RA, Hartwig JH: Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 147: 1299-1312, 1999
22. Passwell J, Schreiner GF, Nonaka M, Beuscher HU, Colten HR: Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis. J Clin Invest 82: 1676-1684, 1988
23. Bao L, Haas M, Boackle SA, Kraus DM, Cunningham PN, Park P, Alexander JJ, Anderson RA, Culhane C, Holers VM, Quigg RJ: Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J Immunol 168: 3601-3607, 2002
24. McKenzie SE, Taylor SM, Malladi P, Yuhan H, Cassel DL, Chien P, Schwartz E, Schreiber AD, Surrey S, Reilly MP: The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol 162: 4311-4318, 1999
25. Quigg RJ: Complement and the kidney. J Immunol 171: 3319-3324, 2003
26. Couser WG: Mediation of immune glomerular injury. J Am Soc Nephrol 1: 13-29, 1990
27. Dixon FJ, Wilson CB: The development of immunopathologic investigation of kidney disease. Am J Kidney Dis 16: 574-578, 1990
28. Fennell RH Jr, Pardo VM: Experimental glomerulonephritis in rats. Lab Invest 17: 481-488, 1967
29. Bolton WK, Sturgill BC: Bovine serum albumin chronic serum sickness nephropathy in rats. Br J Exp Pathol 59: 167-177, 1978
30. Arisz L, Noble B, Milgrom JR, Brentjens JR, Andres GA: Experimental chronic serum sickness in rats. A model of immune complex glomerulonephritis and systemic immune complex deposition. Int Arch Allergy Appl Immunol 60: 80-88, 1979
31. Noble B, Milgrom M, Van Liew JB, Brentjens JR: Chronic serum sickness in the rat: Influence of antigen dose, route of antigen administration and strain of rat on the development of disease. Clin Exp Immunol 46: 499-507, 1981
32. Noble B, Van Liew JB, Brentjens JR: A transition from proliferative to membranous glomerulonephritis in chronic serum sickness. Kidney Int 29: 841-848, 1986
33. Iida H, Izumino K, Asaka M, Takata M, Mizumura Y, Sasayama S: Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats. Clin Exp Immunol 67: 130-134, 1987
34. Furness PN, Turner DR: Chronic serum sickness glomerulonephritis: Removal of glomerular antigen and electrondense deposits is largely dependent on plasma complement. Clin Exp Immunol 74: 126-130, 1988
35. Koffler D, Biesecker G, Noble B, Andres GA, Martinez-Hernandez A: Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis. J Exp Med 157: 1885-1905, 1983
36. Couser WG, Baker PJ, Adler S: Complement and the direct mediation of immune glomerular injury: A new perspective. Kidney Int 28: 879-890, 1985
37. McLeish KR, Gohara AF, Gunning WT III: Chronic serum sickness in the mouse. Relationship of antigen dose to glomerular pathology. Nephron 31: 82-88, 1982
38. Hagstrom GL, Bloom PM, Yum MN, Lavelle KJ, Luft FC: Ferritin- and apoferritin-induced immune complex glomerulonephritis in mice. Nephron 24: 127-133, 1979
39. Brandt J, Pippin J, Schulze M, Hansch GM, Alpers CE, Johnson RJ, Gordon K, Couser WG: Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49: 335-343, 1996
40. Sawtell NM, Hartman AL, Weiss MA, Pesce AJ, Michael JG: C3 dependent, C5 independent immune complex glomerulopathy in the mouse. Lab Invest 58: 287-293, 1988
41. Border WA, Ward HJ, Kamil ES, Cohen AH: Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest 69: 451-461, 1982
42. Iskandar SS, Zhang JM, Rodriguez E: Nephropathy induced in a nephritis-resistant inbred mouse strain with the use of a cationized antigen. Am J Pathol 123: 67-72, 1986
43. Adler S, Salant DJ, Dittmer JE, Rennke HG, Madaio MP, Couser WG: Mediation of proteinuria in membranous nephropathy due to a planted glomerular antigen. Kidney Int 23: 807-815, 1983
44. Sheerin NS, Springall T, Carroll M, Sacks SH: Altered distribution of intraglomerular immune complexes in C3-deficient mice. Immunology 97: 393-399, 1999
45. Nangaku M, Couser WG: Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol 9: 183-191, 2005
46. Russell SM, Harrison PM: Heterogeneity in horse ferritins. A comparative study of surface charge, iron content and kinetics of iron uptake. Biochem J 175: 91-104, 1978
47. Quigg RJ, Lim A, Haas M, Alexander JJ, He C, Carroll MC: Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int 53: 320-330, 1998
48. Bartolotti SR, Peters DK: Delayed removal of renal bound antigen in decomplemented rabbits with acute serum sickness. Clin Exp Immunol 32: 199-206, 1978
49. Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS: Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J Immunol 166: 6444-6451, 2001
50. Ollert MW, David K, Bredehorst R, Vogel CW: Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b. J Immunol 155: 4955-4962, 1995
51. Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS: Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. Kidney Int 65: 129-138, 2004
52. Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS: Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol 164: 786-794, 2000
53. Holers VM, Thurman JM: The alternative pathway of complement in disease: Opportunities for therapeutic targeting. Mol Immunol 41: 147-152, 2004